期刊文献+

HDGF和VEGF在胃癌组织中的表达及其与肿瘤血管生成的关系 被引量:4

Relationship of HDGF and VEGF Expression with Gastric Cancer Angiogenesis
下载PDF
导出
摘要 目的探讨肝癌衍生生长因子(HDGF)、血管内皮生长因子(VEGF)在胃癌组织中的表达与肿瘤组织微血管密度(MVD)之间的关系和临床意义。方法通过免疫组化SP法检测83例胃癌组织、35例正常胃组织中HDGF、VEGF和CD105标记的MVD表达情况,分析它们与胃癌临床病理特征的关系。结果 HDGF、VEGF在胃癌组织中的阳性表达率分别为:66.1%和80.7%,明显高于正常对照组的阳性表达率17.1%和11.4%(P<0.05),胃癌组织中的MVD值为:(33.56±7.59)明显高于常对照组(10.7±3.8)(P<0.05)。HDGF、VEGF的表达强度以及MVD值和肿瘤浸润深度、临床分期、淋巴结转移有明显的相关性(P<0.05)。两者在胃癌组织中的表达存在着正相关(P<0.05)。HDGF、VEGF阳性表达胃癌组织的MVD值明显高于阴性表达的MVD值(P<0.05)。结论 HDGF、VEGF的过表达和微血管生成可能与肿瘤的发生和恶性行为有关,检测该指标对预测胃癌的预后和指导治疗有一定的参考价值。 Objective To investigate the relationship between the expression of hepatoma-derived growth factor (HDGF) and vascular endothelial growth factor (VEGF) and microvessel density of gastric cancer and its significance. Methods The expressions of HDGF, VEGF and MVD in 83 cases of gastric cancer and 35 cases of normal gastric tissue were detected by SP immunohistochemical method, and then their correlations with clinicopathological characteristics were analyzed. Results Positive rates of HDGF (66.1%) and VEGF expressions (80.7%) were significantly higher in gastric cancer tissues than those in the normal gastric tissues (17.1% and 11.4% respectively, P〈0.05) and so did the MVD which was (33.56±7.59) in gastric cancer and (10.7±3.81) in the normal gastric tissues (P〈0.05). The expression of I-IDGF, VEGF and MVD were closely correlated to the invasive depth, lymph node metastasis and TNM staging of gastric cancer(P〈0.05). The expressions of HDGF were positively correlated with the expressions ofVEGF (P〈0.05). The values of MVD in cases with positive expression of HDGF and VEGF were significantly higher than in cases with negative expression of them(P〈0.05). Conclusion Overexp ression of HDGF and VEGF and angiogenesis might contribute to the tumorigenesis and malignant behaviors of gastric cancer. Detecting the expression of HDGF, VEGF and MVD value probably can predict the prognosis of gastric cancer.
作者 周强 何庆
出处 《中国医药指南》 2013年第12期67-70,共4页 Guide of China Medicine
关键词 肝癌衍生生长因子 血管内皮生长因子 微血管密度 免疫组化法 胃癌 Hepatoma derived growth factor Vascular endothelial growth factor Microvessel density Immunohistochemical method Gastric cancer
  • 相关文献

参考文献16

  • 1Nakamura H,Izumoto Y,Kambe H,et al.Molecular cloning of complementary DNA for a novel human hepatoma-derived growth factor:its homology with high mobility group-1protein[J].J Biol Chem,1994,269(40):25143-25149.
  • 2Yoshida K,Tomita Y,Okuda Y,et al.Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma[J].Ann Surg Oncol,2006,13(2):159-167.
  • 3Yamamoto S,Tomita Y,Hoshida Y,et al.Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma[J].Clin Cancer Res,2006,12(1):117-122.
  • 4吕莉,董卫国,余琼芳,罗和生.肝细胞瘤衍化生长因子在结直肠腺癌中的表达及与血管形成关系的研究[J].中华消化杂志,2007,27(3):195-196. 被引量:5
  • 5张军,祁娟,郭艳,郭义,富伟能,周宝森,吴广平,韩立波,何安光.HDGF在手术切除非小细胞肺癌中的异常表达及其在预测预后中的意义[J].中国肺癌杂志,2011,14(3):211-218. 被引量:8
  • 6潘宇亮,曹培国,张隽,符慧群.肝癌衍生生长因子在乳腺癌中的表达及其临床意义[J].肿瘤防治研究,2011,38(8):926-929. 被引量:4
  • 7Uyama H,Tomita Y,Nakamura H,et al.Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer[J].Clin Cancer Res,2006,12(20Pt1):6043-6048.
  • 8Yamamoto S,Tomita Y,Hoshida Y,et al.Expression level of hepa-toma-derived growth factor correlates with tumor recurrence of esophageal carcinoma[J].Ann Surg Oncol,2007,14(7):2141-2149.
  • 9Weidner N,Semple J P,Welch W R,et al.Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma[J].N Engl J Med,1991,324(1):1-8.
  • 10Okuda Y,Nakamura H,Yoshida K,et al.Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor[J].Cancer Sci,2003,94(12):1034-1041.

二级参考文献20

  • 1Shintani Y,Higashiyama S,Ohta M,Hirabayashi H,Yamamoto S,Yoshimasu T,Matsuda H,Matsuura N.Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis[J].中国神经肿瘤杂志,2004,2(2):129-129. 被引量:36
  • 2Yoshida K, Tomita Y, Okuda Y,et al. Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma[J].Ann Surg Oncol,2006,13(2):159-167.
  • 3Yamamoto S, Tomita Y, Hoshida Y, et al. Expression Level of Hepatoma -Derived Growth Factor Correlates with Tumor Recurrence of Esophageal Carcinoma[J]. Ann Surg Oncol,2007,14(7):2141-2149.
  • 4Yamamoto S, Tomita Y, Hoshida Y, et al. Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma[J]. Clin Cancer Res, 2006,12(1):117-122.
  • 5Machuy N, Thiede B,Rajalingam K,et al. A global approach combining proteome analysis and phenotypic screening with RNA interference yields novel apoptosis regulators[J] . Mol Cell Proteomics, 2005, 4 (1) :44-55.
  • 6Enomoto H, Yoshida K, Kishima Y,et al. Hepatoma-derived growth factor is highly expressed in developing liver and promotes fetal hepatocyte proliferation [J], Hepatology, 2002,36(6):1519-1527.
  • 7Everett AD, Stoops T, McNamara CA. Nuclear targeting is required for hepatoma -derived growth factor-stimulated mitogenesis in vascular smooth muscle cells[J]. J Biol Chem, 2001,276(40):37564-37568.
  • 8Narron JV, Stoops TD, Barringhaus K, et al.Hepatoma-derived growth factor is expressed after vascular injury in the rat and stimulates smooth muscle cell migration[J]. Pediatr Res, 2006,59(6):778-783.
  • 9Okuda Y, Nakamura H, Yoshida K,et al.Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor[J]. Cancer Sci,2003,94(12):1034-1041.
  • 10Nakamura H, Izumoto Y, Kambe H, et al. Molecular cloning of complementary DNA for a novel human hepatoma-derived growth factor. Its homology with high mobility group-1 protein. J Biol Chem, 1994, 269:25143-25149.

共引文献12

同被引文献74

  • 1甘伙烨,何兴祥,邹湘才,黄世章,廖德贵,苏杭.盲肠造疝原位接种瘤块法建立小鼠大肠癌肝转移模型[J].广东医学,2007,28(6):855-857. 被引量:15
  • 2谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:118-119.
  • 3Nakamura H, Kambe H, Egawa T,et al. Partial purification and chara-cterization of human hepatoma-derived growth fector [J]. ClinChimActa, 1989,183( 3): 273-284.
  • 4Zhao J, Ma MZ, Ren H, et al. Anti-HDGF targets cancer and cancerstromrf stem cells resistant to chemotherapy [J]. Clin Cancer Res,2013,19(13): 3567-3576.
  • 5Tsai HE, Liu GS, Kung ML, et al. Downregulation of hepatoma-derivedgrowth factor contributes to retarded lungmetastasis via inhibition ofepithelial-mesenchymal transition by systemic POMCgene delivery inmelanoma[J]. Mol Cancer Ther, 2013,12(6): 1016-1025.
  • 6Li M, Shen J, Wu X, et aL Downregulated expression of hepatoma-derivedgrowth factor (HDGF) reducesgallbladder cancer cell proliferation andinvasion[J]. Med Oncol, 2013, 30(2):587-587.
  • 7ThirantC, Galan-Moya EM, DuboisLG, et al. Differential proteomicanalysis of human glioblastoma and neural stem cells reveals HDGFas a novel angiogenic secreted factor [J]. Stem Cells, 2012,30(5):845-853.
  • 8Yamamoto S, TomitaY, Hoshida Y, et al .Expression level ofhepatoma-derived growth factor correlates with tumor' recurrence ofesophageal carcinoma[J]. Ann Surg Oncol, 2007, 14(7): 2141-2149.
  • 9Zhao J, Yu HX, Lin L, et al. Interactome study suggests multiplecellular functions of hepatoma-derived growth factor (HDGF) [J].Journal of Proteomics,2011,75(2): 588-602.
  • 10Lin YW, Li CF, Chen HY, et al. The expression and prognosticsignificance of hepatoma-derived growth factor in oral cancer[J]. OralOncology, 2012,48(7): 629-635.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部